- Phase I Clinical Trial of a HER-2/neu Peptide (E75) Vaccine for the Prevention of Prostate-Specific Antigen Recurrence in High-Risk Prostate Cancer Patients
Matthew T. Hueman et al, 2005, Clinical Cancer Research CrossRef - Immunotherapy as a Precision Medicine Tool for the Treatment of Prostate Cancer
Maria Adamaki et al, 2021, Cancers CrossRef